Enliven Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
AVTE
Aerovate Therapeutics, Inc. |
$2.68 | $77.68 M | -1.1 | 4 |
CELC
Celcuity Inc. |
$10.80 | $409.04 M | -3.81 | 87 |
CGEM
Cullinan Oncology, Inc. |
$8.14 | $476.29 M | -2.93 | 111 |
CMPX
Compass Therapeutics, Inc. |
$1.94 | $267.58 M | -5.37 | 35 |
ELYM
Eliem Therapeutics, Inc. |
$5.11 | $342.68 M | -2.3 | 9 |
GOSS
Gossamer Bio, Inc. |
$0.96 | $216.52 M | -3.81 | 144 |
GPCR
Structure Therapeutics Inc. |
$23.74 | $453.52 M | -10.15 | 163 |
IMRX
Immuneering Corporation |
$1.45 | $51.82 M | -0.71 | 66 |
INBX
Inhibrx Biosciences, Inc. |
$12.26 | $177.62 M | 0.11 | 156 |
KRON
Kronos Bio, Inc. |
$0.87 | $53.02 M | -0.61 | 10 |
LYRA
Lyra Therapeutics, Inc. |
$0.11 | $6.69 M | -0.07 | 30 |
MACK
Merrimack Pharmaceuticals, Inc. |
$15.15 | $223.97 M | -168.28 | 0 |
MLTX
MoonLake Immunotherapeutics |
$39.42 | $2.51 B | -20.9 | 100 |
NVCT
Nuvectis Pharma, Inc. |
$10.49 | $244.21 M | -9.41 | 13 |
PMVP
PMV Pharmaceuticals, Inc. |
$1.04 | $54.01 M | -0.91 | 47 |
REPL
Replimune Group, Inc. |
$9.05 | $697.75 M | -2.95 | 331 |
THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
